INRLF (Valneva SE) SpecialCharges


INRLF Valneva SE INRLF
55 GF Score
Price $2.62
GF Value $2.69
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE SpecialCharges?

Special Charges only applies to banks.

INRLF
55GF Score
Valneva SE INRLF
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valneva SE (INRLF) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of $2.62 is trading 2.6% below its estimated GF Value™ of $2.69. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for INRLF:

  • SpecialCharges:
  • GF Value™: $2.69 vs. price of $2.62 (2.6% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the INRLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
55GF Score

Get the complete analysis for INRLF

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.62
Price
$2.69
GF Value